Gastroparesis and constipation are not the same thing, but the data show a parallel relationship for GLP-1 users
In summary, GLP-1GIPLani outperforms GLP-1RGIPR co-agonism and semaglutide to yield greater body weight loss and further improvement of glucose metabolism, with the latter being mediated by improved insulin sensitivity and enhanced suppression of endogenous glucose production
If you experience persistent abdominal pain or other symptoms, consult our team of board-certified gastroenterologists at Digestive Disease Care for proper diagnosis and treatment options
A significant correlation exists between abnormal eating patterns and the development of EDs
61 Overall, SGLT2 are effective in controlling glycemic levels and lowering hepatic lipid content, but histological analyses are necessary to evaluate their effects on MASH
But it may be related to how Wegovy works for weight loss